Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN14792862) titled 'Prostate cancer screening using short MRI and advanced blood tests in younger, high-risk men' on Sept. 10.
Study Type: Observational
Study Design:
Cohort study
Primary Sponsor: Imperial College London
Condition:
Malignant neoplasms of male genital organs
Cancer
Intervention:
This is a single-centre, prospective, blinded, screen-positive cohort study with an embedded randomised Trial Within a Cohort (TWiC) evaluating recruitment strategies.
This study will include 303 men aged 40-49 years who are at higher risk of prostate cancer (for example, due to family history, Black ethnicity, or certain genetic fact...